Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.
about
SIRT3 regulates progression and development of diseases of aging.Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative diseaseLoss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective StudyLow-dose radiation-induced enhancement of thymic lymphomagenesis in Lck-Bax mice is dependent on LET and genderMitochondrial sirtuins and their relationships with metabolic disease and cancer.{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.Using mitochondrial sirtuins as drug targets: disease implications and available compounds.The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human MelanomaDecrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.The emerging and diverse roles of sirtuins in cancer: a clinical perspective.Melatonin improves age-induced fertility decline and attenuates ovarian mitochondrial oxidative stress in miceHsp60 exerts a tumor suppressor function by inducing cell differentiation and inhibiting invasion in hepatocellular carcinoma.Sirtuins and cancer: new insights and cell signaling.Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis.Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.SIRT3 inhibits cell proliferation in human gastric cancer through down-regulation of Notch-1.SIRT3 expression as a biomarker for better prognosis in gastric cancer.Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis.
P2860
Q26864656-E2A7A78D-C544-4AEA-9F73-4A3507F96F2BQ28068499-23853CB8-5E34-47A4-96A8-3FDB2CEC5192Q28272243-DC5FD7CD-77CD-461D-B6A5-77F44E9C10F2Q28390732-C07A09A2-B2A5-4BC5-B2B9-E9CD1206A176Q35320449-3153C775-7784-4317-B601-8775A2B08FA7Q35550985-232E0F3D-3B2C-4D77-A3F9-8E0E91D78D7DQ35967457-8B12D883-E1A8-43D9-8FE9-226DF246E106Q36092546-88C043EE-3A26-44C8-A157-16EF14C88C45Q36730675-9A50ED16-E09B-4091-B01D-E08229943BB6Q37064102-C0FBDF45-EC60-405D-870C-BDEEFF2AEDE5Q37231067-A1A3EA8F-BFB2-43DF-BD52-69DE8AEDC4CAQ37330537-DCC4D181-BACB-4CAC-92B7-2FB6B7EF7DC5Q37708885-C28F0651-7B11-4DDB-B0DE-04C83EB5009DQ38168292-9C2D0CF8-B1FA-4A7E-BFAB-A30FC7FFD78CQ38881949-736EC352-628C-4AFD-A88A-78F18AE57460Q38930521-8D981041-3D97-48E8-8D3C-B39DF8536946Q39319331-EAB26019-2F00-4A6F-9551-692815E2FCFAQ41570382-D5004942-CC3C-41E2-B33A-7D14663A01B4Q41640117-DB53894B-6621-487E-AC07-4D80AA90DFF7Q48388675-97E142EB-7B41-4521-BE24-A402693C8606Q53341637-F3A32A66-0B9B-45C7-B1AC-5CDABF385B82Q55378526-AABF290C-1ECA-4403-8199-5C537D2A32E0
P2860
Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@ast
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@en
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@nl
type
label
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@ast
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@en
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@nl
prefLabel
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@ast
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@en
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Low SIRT3 expression correlate ...... mary hepatocellular carcinoma.
@en
P2093
Chris Zhiyi Zhang
Jingping Yun
Yinghua Pan
P2860
P304
P356
10.1371/JOURNAL.PONE.0051703
P407
P577
2012-12-14T00:00:00Z